pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
PRV-311
Cervical Cancer
Privo Technologies Inc
0
catalysts
Phase 1
PRX-012
Alzheimer's Disease
Prothena Corp Plc
0
catalysts
Phase 1
PRX-019
Neurodegenerative Diseases
Bristol-Myers Squibb Co
0
catalysts
Phase 2
PRX-115
Gouty Arthritis (Gout)
← prev
page 123 of 231
next →
131
Pain
89
Neurology
1
$PLX
Protalix BioTherapeutics, Inc.
0
catalysts
Phase 2
PS-002
IgA Nephropathy (Berger's Disease)
Purespring Therapeutics Ltd
0
catalysts
Phase 1
PSP-001
Norovirus Infections
Prosit Sole Biotechnology (Beijing) Co Ltd
0
catalysts
Phase 2
PSV-359
Solid Tumor
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Phase 2
PT-00114
Generalized Anxiety Disorder (GAD)
Protagenic Therapeutics Inc
0
catalysts
Phase 1
PTH-0300
Atopic Dermatitis (Atopic Eczema)
Protheragen Inc
0
catalysts
Phase 3
PTP-001
Osteoarthritis
Doron Therapeutics Inc
0
catalysts
Phase 2
PTT-936
Solid Tumor
Pyrotech (Beijing) Biotechnology Co Ltd
0
catalysts
Phase 2
PTX-100
Cutaneous T-Cell Lymphoma
Prescient Therapeutics Ltd
0
catalysts
Preclinical
PTX-252
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Pleco Therapeutics BV
0
catalysts
Phase 2
PTX-9908
Hepatocellular Carcinoma
C-X-C chemokine receptor type 4
Pertinax Therapeutics Inc
0
catalysts
PURIFIED CORTROPHIN GEL
PURIFIED CORTROPHIN GEL (REPOSITORY CORTICOTROPIN)
ANI PHARMS
0
catalysts
Preclinical
PV-001
Glioblastoma Multiforme (GBM)
Primevax Immuno Oncology Inc
0
catalysts
Preclinical
PV-305
Keratitis
VisiRose Inc
0
catalysts
Phase 2
PVX-108
Peanut Allergy
Aravax Pty Ltd
0
catalysts
Phase 2
PVX-7
Human Papillomavirus (HPV) Associated Cancer
PapiVax Biotech Inc
0
catalysts
Phase 2
PXL-065
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Poxel SA
0
catalysts
Preclinical
PXL-770
Polycystic Kidney Disease
Poxel SA
0
catalysts
Phase 1
PYC-003
Polycystic Kidney Disease
PYC Therapeutics Ltd
0
catalysts
Preclinical
Pan-Coronavirus
Coronavirus Disease 2019 (COVID-19)
$DCOY
Decoy Therapeutics Inc.
0
catalysts
Phase 2
Panaecin
Panaecintm (gallium citrate)
Chronic Lung Infection
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
Parathyroid Hormone Inverse Agonist (PTH-IA)
Mutational Disorders
National Center for Advancing Transitional Sciences
0
catalysts
Preclinical
Parkinson's Disease
Parkinson's Disease
Metallomix Inc
0
catalysts
Marketed
Paser
Paser (para aminosalicylic acid [INN])
Tuberculosis
Eurocept Pharmaceuticals
0
catalysts
Phase 2
Peanut SLIT-tablet
Peanut Allergy
ALK-Abello AS
0
catalysts
Preclinical
Peptide Derivative
Acute Respiratory Distress Syndrome
PharmaIN Corp
0
catalysts
Preclinical
Peptide for Glioma
Malignant Glioma
University Hospital Basel
0
catalysts
